Mira Pharmaceuticals (MIRA) Total Assets (2022 - 2026)
Mira Pharmaceuticals (MIRA) total assets from Dec 31, 2022 to Mar 31, 2026. The current Mira Pharmaceuticals (MIRA) total assets is $9.46M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Total Assets
Total Assets
Mira Pharmaceuticals (MIRA) Total Assets CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +150.22% |
| 3 Years TTM | +223.26% |
| All Time TTM | +24.41% |
Annual Total Assets change of Mira Pharmaceuticals (MIRA)
| Year | Total Assets | Change |
|---|---|---|
| 2025 | $11M | +279.79% |
| 2024 | $2.92M | -40.77% |
| 2023 | $4.93M | +473.26% |
| 2022 | $860K | N/A |
Comparison Mira Pharmaceuticals (MIRA) total assets with competitors
Mira Pharmaceuticals (MIRA) total assets is $9.46M.
| Ticker | Name | Total Assets | Upside |
|---|---|---|---|
| NVO | Novo Nordisk | $559.22B | +5911327.06% |
| PFE | Pfizer Inc | $207.62B | +2194593.45% |
| JNJ | Johnson & Johnson | $200.89B | +2123515.22% |
| ABBV | Abbvie Inc | $136.46B | +1442426.43% |
| MRK | Merck & Co Inc | $128.69B | +1360206.55% |
| SNY | Sanofi | $128.02B | +1353219.24% |
| NVS | Novartis AG | $118.53B | +1252880.97% |
| LLY | Lilly(Eli) & Company | $116.58B | +1232204.44% |
| AZN | Astrazeneca plc | $114.02B | +1205132.56% |
| AMGN | AMGEN Inc | $92.50B | +977743.55% |
| BMY | Bristol-Myers Squibb Company | $86.48B | +914022.62% |
| GSK | GSK Plc | $82.91B | +876277.91% |
| GILD | Gilead Sciences Inc | $56.28B | +594804.86% |
| BIIB | Biogen Inc | $29.48B | +311560.68% |
| GRFS | Grifols SA | $20.10B | +212362.36% |
| OGN | Organon & Company | $13.00B | +137278.44% |
| AMRN | Amarin Corp | $645.76M | +6726.26% |
| SCLX | Scilex Holding Company | $293.63M | +3003.96% |
| MDCX | MDCorp | $7.43M | -21.49% |
| MDCXW | Medicus Pharma Ltd warrant | $7.43M | -21.49% |
| NSRX | Nasus Pharma Ltd | $5.00M | -47.10% |